NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Guideline Alliance (UK). Cystic Fibrosis: Diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2017 Oct 25. (NICE Guideline, No. 78.)
Table 94Parameters for Weibull distribution used to derive CF survival projections, reproduced from Vertex’s submission for NICE TA398
| Parameter | Value/formula |
|---|---|
| λ | 3.938E-07a |
| γ | 3.2577 |
| S(t) | exp (-λt^γ) |
| h(t) | λγ^t-1 |
| H(t) | λt^γ |
- a)
corrected from 3.938E-06
- Table 94, Parameters for Weibull distribution used to derive CF survival project...Table 94, Parameters for Weibull distribution used to derive CF survival projections, reproduced from Vertex’s submission for NICE TA398 - Cystic Fibrosis
- Homo sapiens syndecan 3 (SDC3), mRNAHomo sapiens syndecan 3 (SDC3), mRNAgi|1519241601|ref|NM_014654.4|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...